Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Sort descending Drug Company PI Date Risk List Available?
Etravirine (Intelence) Janssen Therapeutics July 2019 YES
Hydroxychloroquine Actavis Pharma November 2017
Imatinib Mesylate Sun Pharmaceutical Industries, Inc. November 2018
Intralipid Fresenius Kabi Limited April 2016
Isoniazid Teva Pharmaceuticals USA, Inc. March 2018
Isoniazid Macleods Pharmaceuticals Ltd August 2015
Isoniazid Sandoz Inc. October 2018
Lamivudine (Epivir) - New GlaxoSmithKline September 2020 YES
Lamivudine/Zidovudine (Combivir) GlaxoSmithKline April 2018 YES
Ledipasvir/Sofosbuvir (Harvoni) Gilead November 2019
Levonorgestrel Northstar Rx April 2018
Lopinavir/Ritonavir (Kaletra) AbbVie December 2019 YES
Losartan Potassium (Cozaar) Merck October 2018
Maraviroc (Selzentry) - New ViiV Healthcare October 2020 YES
Medroxyprogesterone Acetate (DEPO-PROVERA CI) Pfizer January 2017
Nevirapine (Viramune) Boehringer Ingelhiem Pharmaceuticals September 2018 YES
Peginterferon alfa 2b (Pegintron) Merck January 2019
Pitavastatin (Livalo) Kowa October 2019
Pravastatin Sandoz December 2006
Pyrazinamide Macleods Pharmaceuticals Limited May 2014